# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Bladder cancer

Small cell carninoma of the bladderPoorly differentiated neuroendocrine carcinoma of the bladder;SCCBSmall cell bladder cancerSmall cell bladder carcinoma; Small cell carcinoma of the urinary bladderBladder carcinoma
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 357 results.
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Status: Recruiting
Last Changed: Jul 07, 2020
First Received: Dec 03, 2019
Disease(s): Bladder Cancer
Intervention(s): Dendritic cells, Standard treatment according to the Clinical protocols
Locations: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Multidisciplinary Bladder-preservation Therapy for Bladder Cancer
Status: Recruiting
Last Changed: Nov 28, 2018
First Received: Nov 28, 2018
Disease(s): Bladder Cancer
Intervention(s): multidisciplinary bladder-preservation therapy
Locations: Peking University Third Hospital, Beijing, Beijing, China
Biomarker Identification for Bladder Cancer Patients
Status: Recruiting
Last Changed: Jul 13, 2020
First Received: Feb 04, 2014
Disease(s): Bladder Cancer
Intervention(s): Sample Collection
Locations: The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Aug 19, 2019
Disease(s): Bladder Cancer
Intervention(s): Paclitaxel-binding albumin
Locations: Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Status: Recruiting
Last Changed: Jul 05, 2019
First Received: Jan 25, 2016
Disease(s): Bladder Cancer
Intervention(s): Pembrolizumab, Cisplatin, Radiotherapy
Locations: Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
Liverpool Hospital, Liverpool, New South Wales, Australia
Prince of Wales Hospital, Randwick, New South Wales, Australia
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Austin Health, Heidelberg, Victoria, Australia
... and 3 other locations.
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jun 12, 2019
Disease(s): Bladder Cancer
Intervention(s): Instillation of IMUNO BCG Moreau RJ
Locations: Hospital Universitario Basurto, Bilbao, Spain
Complejo Hospitalario Puerta Del Mar, Cadiz, Spain
Complexo Hospitalario Universitario A Coruña, Coruña, Spain
Complejo Hospitalario Regional Reina Sofía, Córdoba, Spain
Hospital Universitario Virgen de Las Nieves, Granada, Spain
... and 11 other locations.
Consolidative Radiotherapy Versus Observation for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
Status: Recruiting
Last Changed: Jul 07, 2020
First Received: Jun 11, 2020
Disease(s): Urothelial Bladder Cancer
Intervention(s): Experimental arm
Locations: Clinique Claude Bernard, Albi, France
Institut de Cancerologie de L'Ouest, Angers, France
Institut Bergonie, Bordeaux, France
Chu Morvan, Brest, France
Centre Francois Baclesse, Caen, France
... and 8 other locations.
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Status: Recruiting
Last Changed: Nov 20, 2019
First Received: Sep 01, 2016
Disease(s): Bladder Cancer
Intervention(s): Celecoxib, Gemcitabine, Cisplatin
Locations: Baylor Clinic, Houston, Texas, United States
Harris Health System - Smith Clinic, Houston, Texas, United States
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
Status: Recruiting
Last Changed: Nov 07, 2019
First Received: Dec 12, 2018
Disease(s): Muscle Invasive Bladder Cancer
Intervention(s): Durvalumab, Oleclumab
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study
Status: Not yet recruiting
Last Changed: Jul 24, 2018
First Received: Jul 24, 2018
Disease(s): Bladder Cancer
Intervention(s): Anesthesia before transurethral resection of the bladder tumor, Anesthesia
Locations: Seoul National University Hospital, Seoul, Korea, Republic of